Topical and systemic skin aging interventions: Evidence, pitfalls and perspectives.

Area of Science:

• Dermatology and Pharmaceutical Sciences
• Gerontology
• Cosmetic Science

Background:

• Skin aging results from intrinsic and extrinsic factors, notably ultraviolet radiation.
• Numerous topical and systemic interventions aim to mitigate visible skin aging.
• Existing reviews often lack a pharmaceutical and methodological evidence assessment.

Purpose of the Study:

• To critically evaluate current skin aging interventions from pharmaceutical and clinical evidence perspectives.
• To identify limitations in the existing literature and research methodologies.
• To highlight the gap between commercial claims and scientific validation for anti-aging products.

Main Methods:

• Comprehensive review of scientific literature on skin aging interventions.
• Integration of pharmaceutical considerations (physicochemical properties, bioavailability, stability).
• Methodological assessment of clinical trial designs and outcome measures.

Main Results:

• Clinical effectiveness of many interventions is limited by poor absorption, instability, or irritation.
• The literature is often characterized by small sample sizes, short durations, and subjective endpoints.
• Retinoids show consistent support but have tolerability concerns; evidence for others (antioxidants, hormones, hyaluronic acid, collagen peptides) is inconclusive.

Conclusions:

• A significant discrepancy exists between commercial claims and robust clinical evidence for skin aging interventions.
• Current research methodologies often lack rigor, limiting the reliability of reported benefits.
• There is a critical need for large-scale, independent, well-controlled trials with objective endpoints to guide effective and safe anti-aging strategies.